Rhythm Pharmaceuticals, Inc. (RYTM) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of$0.70. This compares to loss of $0.82 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 21.43$2.34 per share when it actually produced a loss of $2.35, delivering a surprise of -0.43%.Over the last four quarters, the company ...